Navigation Links
Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Date:1/26/2009

SEATTLE, Jan. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) announced today that after communication with the Food and Drug Administration (FDA), CTI expects to begin submission of a rolling New Drug Application (NDA) and request priority review for pixantrone to treat relapsed aggressive non-Hodgkin's lymphoma (NHL) in the first quarter of 2009. If granted priority review a decision on the NDA could occur before the end of 2009.

"This communication from the FDA is a significant milestone for the Company and for patients with relapsed aggressive NHL as this could be the first drug approved for this unmet medical need," noted James A. Bianco, M.D. Chief Executive Officer of CTI. "With the potential for three drug approvals in 2009 we are on track to meet our objective of cash flow break even in the fourth quarter of this year."

The EXTEND clinical trial was a phase III single-agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or more prior therapies and who were sensitive to treatment with anthracyclines. The trial enrolled 140 patients and patients were randomized to receive either pixantrone or another single-agent drug currently used for the treatment of this patient population and selected by the physician.

CTI announced in November 2008 that it had achieved the primary efficacy endpoint of its phase III EXTEND (PIX301) trial of pixantrone (BBR2778). Patients randomized to treatment with pixantrone achieved a high rate of confirmed and unconfirmed complete remissions compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02). No patient (0%) in the standard chemotherapy arm achieved a confirmed complete remission compared to 8/70 (11%) of pixantrone recipients. Pixantrone treatment also significantly increa
'/>"/>

SOURCE Cell Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
2. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
3. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
4. Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
5. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
6. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
7. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
8. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
9. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
10. Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts
11. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Oregon , May 28, 2015 ... "Global Syphilis Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth ... to reach $3.6 billion by 2020. The secondary syphilis ... through 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue ...
(Date:5/28/2015)... DIEGO , May 28, 2015  Service ... programs, today announced that Fresenius Kabi, a global ... technologies for infusion, transfusion and clinical nutrition, has ... & Performance (SCP) Standards for the seventh ... quantify service effectiveness based upon a stringent set ...
(Date:5/28/2015)... FORT WORTH, Texas , May 28, 2015 /PRNewswire/ ... defines and segments the concerned market with analysis and ... million in 2014 and is estimated to reach $1,177.8 ... 2014 to 2019. Browse through the TOC ... the industry trends and segments, with help of various ...
Breaking Medicine Technology:Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 2Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 3Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3
(Date:5/28/2015)... Workers’ compensation costs per claim in Michigan were lower ... the Workers Compensation Research Institute (WCRI) said, with ... WCRI study, CompScope™ Benchmarks for Michigan, 15th Edition, ... more of work with those of 16 other states. ... 4 percent lower than similar claims from 2008. That was ...
(Date:5/28/2015)... May 28, 2015 Baptist Medical Center ... patients suffering from acute stroke or other neurological conditions. ... one of a few in the country and the ... emergency needs such as brain aneurysms. , “Baptist ... care of patients who are impacted by stroke,” said ...
(Date:5/28/2015)... Houston, TX (PRWEB) May 28, 2015 ... respected cosmetic surgeons , has announced that the new ... Accreditation. The American Association of Accreditation of Ambulatory Surgery ... state-of-the-art surgery center . , According to Dr. ... for meeting the standards of a Class C ambulatory ...
(Date:5/28/2015)... Sexual Health Innovations, a nonprofit ... health and wellbeing in the United States, announced ... (USF) will be the first institution to adopt ... reporting system. , Callisto is designed to ... experience for college sexual assault survivors, to give ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 A bucket ... adventures. Each item on the bucket list ... events, experiences and tasks that the owner wants to ... right or wrong when it comes to making this ... business, writing poems, publishing a book, seeing the Grand ...
Breaking Medicine News(10 mins):Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3
... of expertise and other factors when ... ... CIGNA Behavioral Health,(CBH) members can now view robust, online ... including license,levels, languages spoken, educational background, areas of specialization,and years ...
... -- Researchers at Mayo Clinic in Jacksonville have discovered how ... proteins in the brain, resulting in a common dementia, ... number of age-related neurological disorders. , In the Sept. ... that absence of a gene known as progranulin leads to ...
... be on,display throughout The Kroger Co.,s (NYSE: KR ... partners with vendors and suppliers to support,National Breast Cancer ... tags can be found on shelves in Kroger,stores across ... support breast cancer awareness in their community. Several of,Kroger,s ...
... Climb to Conquer Cancer will follow four professional U.S., ... Alaska, NEW YORK, Sept. 27 Fred Hutchinson ... expedition to an unclimbed,mountain in the name of cancer ... expedition. The inaugural Climb to Conquer Cancer, performed ...
... QMed, Inc.,(Nasdaq: QMED ) today announced it ... August 31, 2007 revenue of approximately $10.8 million and,$26.6 ... $13 million,respectively. The Company,s cash position as of August ... Jane Murray, president and CEO, said, "During the ...
... Edition Strawberry Jelly Krimpets Will Benefit Online ... for Breast Cancer Support and Information, PHILADELPHIA, Sept. ... philanthropic product offering, the,Tastykake Strawberry Jelly Krimpet. 10% of ... will be donated to breastcancer.org, a,Narberth, Pennsylvania based online ...
Cached Medicine News:Health News:CIGNA Behavioral Health Offers Members Online Provider Profiles 2Health News:Loss of gene leads to protein splicing and buildup of toxic proteins in neurons 2Health News:Kroger 'Pink Tag' Campaign to Raise $2.5 Million for Breast Cancer Awareness in October 2Health News:Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research 2Health News:QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million 2Health News:QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million 3Health News:Tasty Baking Company Launches New Krimpet to Support Breast Cancer Awareness Through a Partnership with Breastcancer.Org 2Health News:Tasty Baking Company Launches New Krimpet to Support Breast Cancer Awareness Through a Partnership with Breastcancer.Org 3
Inquire...
Inquire...
Inquire...
... operation and optical performance, the SZX7 is ... comfort in every task, from routine preparations ... of the best zoom ratios in its ... true color and accurate reproduction of the ...
Medicine Products: